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Recent genomic studies have revealed extensive variation in natural populations of many pathogenic
bacteria. However, the evolutionary processes which contribute to much of this variation remain unclear. A
previous whole-genome DNA microarray study identified variation at a large chromosomal region (RD13) of
Staphylococcus aureus which encodes a family of proteins with homology to staphylococcal and streptococcal
superantigens, designated staphylococcal exotoxin-like (SET) proteins. In the present study, RD13 was found
in all 63 S. aureus isolates of divergent clonal, geographic, and disease origins but contained a high level of
variation in gene content in different strains. A central variable region which contained from 6 to 10 different
set genes, depending on the strain, was identified, and DNA sequence analysis suggests that horizontal gene
transfer and recombination have contributed to the diversification of RD13. Phylogenetic analysis based on the
RD13 DNA sequence of 18 strains suggested that loss of various set genes has occurred independently several
times, in separate lineages of pathogenic S. aureus, providing a model to explain the molecular variation of
RD13 in extant strains. In spite of multiple episodes of set deletion, analysis of the ratio of silent substitutions
in set genes to amino acid replacements in their products suggests that purifying selection (selective constraint)
is acting to maintain SET function. Further, concurrent transcription in vitro of six of the seven set genes in
strain COL was detected, indicating that the expression of set genes has been maintained in contemporary
strains, and Western immunoblot analysis indicated that multiple SET proteins are expressed during the
course of human infections. Overall, we have shown that the chromosomal region RD13 has diversified
extensively through episodes of gene deletion and recombination. The coexpression of many set genes and the
production of multiple SET proteins during human infection suggests an important role in host-pathogen
interactions.
Staphylococcus aureus causes a variety of diseases in humans
and animals and produces a large number of secreted proteins
which contribute to infection (4, 7). Recent comparative
genomic studies have revealed a high level of interstrain vari-
ation in genome content, particularly at regions containing
genes encoding virulence factors or antibiotic resistance mech-
anisms (2, 5, 6). For example, a recent DNA microarray study
examining genomic variation in S. aureus identified 18 large
chromosomal regions of difference among 36 strains isolated
from different infection types in humans, cows, and sheep (6).
Among the 18 large chromosomal regions identified, one
(RD13) varied in size from 12 to 17 kb and was predicted to
contain considerable variation in gene content (Fig. 1). RD13
corresponds to the exotoxin gene-containing regions of geno-
mic islands SaPIn2 and SaPIm2, identified in S. aureus strains
N315 and Mu50, respectively (10). RD13 has open reading
frames encoding hypothetical proteins, a transposase, a restric-
tion-modification system, and at least seven staphylococcal
exotoxin-like (SET) proteins, depending on the strain (Fig. 1).
Analysis of the inferred amino acid sequences indicates that
SET proteins contain internal regions of homology with super-
antigens made by S. aureus and group A Streptococcus. Super-
antigens produced by S. aureus and group A Streptococcus are
thought to modulate the host immune response during infec-
tion by binding and activating T-cell subsets expressing specific
V chains of the T-cell receptor (4, 11, 14). However, a very
recent study reported that a purified recombinant SET variant
did not have the classical characteristics of superantigens, such
as mitogenicity, pyrogenicity, or the enhancement of endotoxic
shock (1). A representative SET (SET3) has the classical three-
dimensional structure which is characteristic of superantigens,
but there are some notable differences perhaps reflecting an
alternative function. In particular, SET3 has a large, positively
charged, saddle-shaped surface that has the potential to act as
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a binding surface for negatively charged molecules such as
DNA (1). However, the function of this family of proteins has
yet to be established.
The precise molecular processes leading to genome diversi-
fication in pathogenic bacteria remain unclear. Many of the
variable chromosomal regions identified in the genome of S.
aureus are related to insertion elements, transposons, phage,
and pathogenicity islands and are found in only a portion of
strains examined, indicating the role of horizontal gene trans-
fer in S. aureus evolution. However, a large region (RD13) of
the chromosome with extensive variation in virulence gene
content was identified in all strains examined by microarray
analysis. The unusual variation in nucleotide and gene content
of RD13 raised important questions regarding the processes
that have contributed to the genetic diversity of RD13 and to
the evolution of the S. aureus genome in general. In the present
study, comparative sequencing, PCR-restriction fragment
length polymorphism (RFLP) analysis, gene and protein ex-
pression assays, and evolutionary genetic analyses were used to
investigate the molecular evolution and genetic diversity of
RD13 in strains of S. aureus isolated from human and animal
infections. A model for the evolutionary history of RD13
among pathogenic clones is proposed.
MATERIALS AND METHODS
S. aureus strains. Strains were selected to represent the most abundant clonal
lineages identified in a multilocus enzyme electrophoresis (MLEE) population
genetic study of over 2,000 S. aureus isolates and were of broad geographic and
disease origin (Table 1) (12).
RD13 PCR-RFLP analysis. PCR primers (forward primer, 5-CAA AGC TAA
ACA AGA CGG CTT TGA TG-3; reverse primer, 5-TCC GCG CCA ATC
TTC TGG AAC-3) specific for conserved regions flanking RD13 were used to
amplify the intervening sequence with the Advantage genomic PCR kit (Clon-
tech, Palo Alto, Calif.) according to the manufacturer’s instructions. The PCR
products were digested with restriction endonuclease HinP1I at 37°C for 2 h, and
the DNA restriction fragments were resolved by electrophoresis in a 1.2% aga-
rose gel.
Analysis of size variation in Vr in RD13. The size of the RD13 variable region
(Vr) in each strain was inferred on the basis of amplification by PCR with
primers (forward primer, 5-ATA GAA CTC GCC TGC TTT TTT ACC-3;
reverse primer, 5-CCA AAG CCT TTA GGT TCA TCA TAC A-3) specific for
conserved flanking regions (the mod and orf3 genes, respectively) (Fig. 1)
DNA sequence analysis. Sequence data obtained from both DNA strands with
an Applied Biosystems model 3700 automated sequencer were analyzed by
DNASTAR (Madison, Wis.). Multiple-sequence alignment of the inferred
amino acid sequences was performed with Clustal W version 1.8 (18). Statistics
of nucleotide and amino acid content were determined with MEGA version 2.1
(9).
Population and molecular evolutionary genetic analyses. The Nei-Gojobori
method (13) was used to calculate the proportion of synonymous sites in nucle-
otide sequence data. Phylogenies were constructed with the neighbor-joining
algorithm by using MEGA version 2.1 (9). A concatenated sequence consisting
of orf2, set1, res, mod, set2, set3, set9, set10, and set11 was used for the analysis of
the conserved architecture of RD13. Due to strain-to-strain variation in the
content of certain set genes, set4, set5, set6, set7, and set8 were studied indepen-
dently. To examine variation in the patterns of nucleotide substitution, the
proportion of synonymous (pS) and the proportion of nonsynonymous (pN)
nucleotide substitutions were calculated by sliding-window analysis of 30 codons
along each gene with the program PSWIN (15) (PSWIN is available from S. D.
Reid [sreid@niaid.nih.gov]). Estimates of the sampling variance of these statis-
tics were made by Monte Carlo simulation or by bootstrapping.
To identify the putative end points of past recombination events, a computer
program (MAXCHI) that implements the maximum chi-square method was used
(16). Happlot analysis was used to diagram the locations of polymorphic sites.
Real-time reverse transcriptase PCR (TaqMan assays). PCR primers and
probes were designed with the software package Primer Express (Perkin-Elmer)
on the basis of the genomic DNA sequence available for S. aureus strain COL
(http://www.tigr.org) and purchased from PE Applied Biosytems. Total RNA was
isolated from bacteria cultured for 3 h (mid-exponential phase) or 12 h (station-
ary phase), and reverse transcription and PCRs were performed as described
previously (3). To confirm that the era gene encoding the GTP-binding protein
Era was constitutively expressed and suitable for use as an internal control, the
amount of era mRNA was measured in three separate reverse transcriptase PCR
experiments with two independent RNA samples isolated from mid-exponential
FIG. 1. Genetic structure of chromosomal region RD13 in eight S. aureus strains: 8325, Sanger MSSA, MW2, Sanger MRSA, N315, Mu50,
COL, and NCTC6571. The proteins encoded by the genes designated are as follows: orf1 to orf5 (white), hypothetical proteins; set1 to set11 (blue),
staphylococcal exotoxin-like proteins; res and mod (green), restriction-modification subunits; tra (red), transposase. Dashed lines represent DNA
of unknown sequence. The central Vr is indicated.
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TABLE 1. PCR-RFLP types of S. aureus strains of divergent clonal lineages
Straina Lineage/electro-phoretic typeb
Disease or
characteristicc
Source
(date of isolation)d
PCR-RFLP
type
Vr size
(kb)
COL ND MR Colindale, United Kingdom 1 7
MSA 1401 A1/1 Bovine mastitis Cornell 25 9
MSA 951 A1/5 Bovine mastitis Louisiana 24 10
MSA 948 A1/7 Bovine mastitis Puerto Rico 22 11
MSA 2050 B1/10 Endocarditis Denmark (1985) 23 9
MSA 2099 D2/32 Endocarditis Denmark (1984) 12 9
MSA 2389 D2/39 Furunculosis Sweden 12 9
MSA 2967 D3/45 Sepsis Canada 13 9
MSA 1601 D3/53 MR Rhode Island 13 9
MSA 915 E1/61 Bovine mastitis Louisiana 18 10
MSA 535 F1/66 Ovine mastitis Germany 11 11
MSA 551 F1/70 Ovine mastitis France 11 11
MSA 3402 F2/89 MR New York (1978) 16 11
MSA 3426 F2/89 MR Dublin, Ireland (1980s) 3 11
MSA 820 F2/91 MR Rhode Island 6 10
MSA 890 F2/93 MR Texas 2 10
MSA 3400 F2/91 MR Dublin, Ireland (1990) 6 10
MSA 3405 F2/91 MR Canada (1980s) 7 9
MSA 3410 F2/93 MR London, United Kingdom (1960s) 1 7
MSA 1006 F3/91 Bovine mastitis Louisiana 3 11
MSA 1007 F3/106 Bovine mastitis Louisiana 3 11
MSA 817 F4/114 Human origin Rhode Island (1980s) 4 10
MSA 961 F4/146 Bovine mastitis Louisiana 5 10
MSA 2120 F4/146 Endocarditis Denmark (1983) 8 11
MSA 2766 F5/161 TSS Canada 32 9
MSA 1605 F5/164 Turkey hock Utah 19 11
MSA 1260 F5/165 Vaginal commensal P. Schlievert 6 10
MSA 573 F6/170 TSS B. Kreiswirth 20 11
MSA 581 F6/170 Human origin B. Kreiswirth 19 11
MSA 565 F8/178 Human origin B. Kreiswirth 3 9
MSA 2020 F9/189 Scalded-skin syndrome France 10 11
MSA 2965 F9/191 Sepsis Canada (1983) 10 11
MSA 2348 F9/189 Furunculosis Sweden 10 11
RF122 F10/195 Bovine mastitis Ireland (1993) 9 9
MSA 632 F11/205 TSST-1 B. Kreiswirth 21 11
MSA 1184 F11/205 W. Karakawa 21 11
MSA 554 GI/213 Chicken B. Kreiswirth 17 8
MSA 537 H1/234 TSS United States (1985) 15 9
MSA 2335 H1/234 TSS Sweden 15 10
MSA 2885 H1/234 Nasal commensal Canada (1974) 15 10
MSA 3407 H1/234 TSS New York (1978) 15 10
MSA 3412 H1/234 TSS New York (1980s) 14 7
MSA 1183 I1/245 R. Proctor 32 9
MSA 1134 K1/249 Human TSST-1 P. Schlievert 6 10
MuSA 141 ND Septicemia (w/o) Finland (1999) 33 9
MuSA 142 ND Septicemia (w) Finland (1999) 16 9
MuSA 143 ND Septicemia (w/o) Finland (1999) 13 9
MuSA 144 ND Septicemia (w) Finland (1999) 6 10
MuSA 145 ND Septicemia (w/o) Finland (1999) 26 10
MuSA 146 ND Septicemia (w) Finland (1999) 8 11
MuSA 147 ND Septicemia (w/o) Finland (1999) 34 8
MuSA 148 ND Septicemia (w) Finland (1999) 27 11
MuSA 149 ND Septicemia (w/o) Finland (1999) 13 9
MuSA 150 ND Septicemia (w) Finland (1999) 28 10
MuSA 231 ND Septicemia (w/o) Finland (2000) 13 9
MuSA 232 ND Septicemia (w) Finland (2000) 34 8
MuSA 233 ND Septicemia (w) Finland (2000) —e 10
MuSA 234 ND Septicemia (w/o) Finland (2000) 13 9
MuSA 236 ND Septicemia (w/o) Finland (2000) 30 9
MuSA 237 ND Septicemia (w) Finland (2000) 13 9
MuSA 238 ND Septicemia (w) Finland (2000) 15 9
MuSA 239 ND Septicemia (w) Finland (2000) 31 10
MuSA 240 ND Septicemia (w/o) Finland (2000) 34 8
a MSA and MuSA, Musser S. aureus strain designations.
b Phylogenetic lineage and electrophoretic type as designated by Musser and Selander (12). ND, not determined.
c MR, methicillin resistant; TSS, toxic shock syndrome; TSST-1, toxic shock syndrome toxin-1 positive; w, with deep infection foci; w/o, without deep infection foci.
d P. Schlievert, culture collection of P. Schlievert; B. Kreiswirth, culture collection of B. Kreiswirth; W. Karakawa, culture collection of W. Karakawa; R. Proctor,
culture collection of R. Proctor.
e —, no product.
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and stationary-phase cultures of strain COL. The results confirmed that era is
expressed at similar levels (0.9 to 1.3 relative expression levels) in both phases of
the growth cycle (data not shown).
set gene cloning and production of recombinant SET proteins. The primers,
vectors, and restriction enzymes used for PCR amplification and cloning of the
set genes of S. aureus strains COL and 8325 are listed in Table 2. The primers
were designed on the basis of genome sequences available for S. aureus strains
COL (http://www.tigr.org) and 8325 (http://www.genome.ou.edu), and restriction
enzyme sites for cloning were included in each primer. PCR products were
amplified with genomic DNA isolated from strain COL or strain 8325, digested
with the appropriate restriction enzymes, and cloned into vector pET21b or
pET15. The cloned genes were sequenced to ensure that spurious mutations had
not been introduced, and the plasmids were moved into Escherichia coli BL21 for
expression of recombinant proteins.
To assess the production of recombinant proteins, BL21 cells with recombi-
nant plasmids were grown at 37°C for 10 h in 3 ml of Luria-Bertani broth
supplemented with 100 mg of ampicillin per liter. Cells were pelleted by centrif-
ugation and suspended in 1 sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) loading buffer at a ratio of 100 l of buffer per 1 unit
of optical density 600 nm per ml. The samples were boiled for 10 min and
analyzed by SDS-PAGE.
Purification of recombinant SET protein. To purify recombinant SET6 pro-
tein, BL21 cells with recombinant plasmid were grown overnight at 37°C in
Luria-Bertani broth. The culture was treated with 4 volumes of absolute ethanol
for 48 h, and the precipitated proteins were collected by centrifugation (500  g,
10 min). Five liters of total culture volume was combined in a single culture toxin
preparation. The precipitate was air dried after centrifugation and resuspended
in 100 to 150 ml of pyrogen-free water. The resuspended precipitate was centri-
fuged at 10,000  g for 30 min; the concentrated supernatant was removed,
placed in dialysis tubing with a 12,000- to 14,000-molecular-weight cutoff (Spec-
trum Laboratories, Inc., Miami, Fla.), and dialyzed overnight against 4 liters of
distilled water. The dialyzed supernatant was subjected to preparative isoelectric
focusing. Successive gradients of pH 3.5 to 10 and pH 6 to 8 were used to isolate
highly purified recombinant SET6 protein. Final purification of proteins was
accomplished with a gel filtration column (Bio-Rad Laboratories, Hercules,
Calif.) containing Sephadex G-75 (Sigma, St. Louis, Mo.). Purity was verified by
SDS-PAGE in which 10 g gave a homogenous band of the appropriate molec-
ular weight. The concentration of the purified protein was assessed with the
Bradford protein assay (Bio-Rad) (2a), and the protein was lyophilized and
stored until used in biological and biochemical assays.
Assay for superantigen activity. Rabbit splenocytes or human peripheral blood
mononuclear cells (PBMCs) were seeded into the wells of a 96-well microtiter
plate at a concentration of 2  105 cells per well. Serial 10-fold dilutions of SET
or toxic shock syndrome toxin 1 (TSST-1; positive control) were added to each
well in quadruplicate, starting with 1 g/well and with dilution to 108 g/well.
The assay results for these dilutions were compared to those for cells incubated
in the presence of phosphate-buffered saline alone. The splenocytes were grown
at 37°C for 3 days and pulsed with 1 Ci of [3H]thymidine overnight. The cells
were harvested the next day, and cell proliferation (incorporation of 3H into
DNA) was measured with a scintillation counter (Beckman Instruments, Fuller-
ton, Calif.).
Pyrogenicity and endotoxin enhancement. American Dutch belted rabbits
were injected intravenously with recombinant SET proteins at a maximal dose of
10 g/kg of body weight per ml. The temperature of each rabbit (n  3) was
measured with a rectal thermometer at 0 and 4 h postinjection. After 4 h, each
rabbit was injected intravenously with 10 g of lipopolysaccharide from Salmo-
nella enterica serovar Typhimurium (1/50 of the 50% lethal dose of endotoxin
alone). The lethality of this toxin regimen was assessed over a 48-h period.
Western immunoblot analysis. Proteins separated by SDS-PAGE were trans-
ferred to nitrocellulose membranes (Immobilon-NC; Millipore Corporation)
with Towbin transfer buffer with a Trans-Blot SD semidry transfer cell (Bio-Rad
Laboratories) at 15 V for 40 min. The membrane was incubated with 10 ml of
block solution (5% powdered milk in 150 mM NaCl and 100 mM Tris-HCl, pH
7.4) for 1 h, incubated for 1 h with a 1:500 dilution of human patient serum in
block solution, rinsed twice, and washed three times for 15 min each time with
0.1% Tween 20 in phosphate-buffered saline. The membrane was incubated with
goat anti-human immunoglobulin G horseradish peroxidase-conjugated second-
ary antibody (Sigma) for 1 h and rinsed and washed as described above. Immu-
noreactivity was visualized by enhanced chemiluminescence. The human serum
samples were obtained during a countrywide study of invasive episodes of S.
aureus infection in Finland in 1999 and 2000. Patients had infections with or
without deep infection foci, including abscesses, cellulitis, pneumonia, and pu-
rulent arthritis. Sera were obtained 2 to 7 days (i.e., the acute phase) and 20 to
30 days (i.e., the convalescent phase) after the first positive blood culture.
Control serum samples were obtained from four female and four male healthy
volunteers, including Caucasian, African-American, Hispanic, and Asian indi-
viduals (n  2 each).
Nomenclature of the SET family of proteins. To date in the literature, there
has been no coherent system regarding the numbering of the members of the
SET protein family. All S. aureus strains examined to date, including the genet-
ically divergent strains in the present study, contained between 7 and 11 different
set genes in RD13. Comparison of RD13 chromosomal regions from different
strains indicates that the overall set gene order of RD13 is conserved and that set
genes at the same position in RD13 in different strains are allelic variants of each
other (85 to 100% homology). Accordingly, we propose that the set gene family
of RD13 should be named set1 to set11 in consecutive order based on strains with
a full complement of set genes in RD13 (Fig. 1). To differentiate between allelic
variants of set genes found in different strains, the gene number should be
prefixed by the strain name, e.g., COLset1.
TABLE 2. Primers, vectors, cloning sites, and recombinant plasmids used in gene cloning
Gene Strain Primers Vector Cloning sites Plasmid
set1 COL 5-CCAGTACATATGAGTACATTAGAGGTTAGATCA-3,
5-CGGATCCTAATATAAATCGACTTCAATTT-3
pET21b NdeI, BamHI pset2289
set2 COL 5-CAGGTCATATGAAACAAAATCAAAAGTCAGTA-3,
5-AGGATCCTACTTTAAGTTAACTTCAATATC-3
pET21b NdeI, BamHI pset2293
set3 COL 5-CTGGTCATATGAAAGTAGAACTTGATGAGACA-3,
5-CGGATCCTAATTCAAATTCACTTCAATAT-3
pET21b NdeI, BamHI pset2294
set4 8325 5-CGGTTCATATGAAAGGAAAGTATGAAAAAATG-3,
5-CGGATCCTATTTCAAATTCACTTCGATGT-3
pET21b NdeI, BamHI pset8325-1
set5 8325 5-GCAGTTCATATGAAAGAAAAGCAAGAGAGAGTA-3,
5-CGGATCCTACTTACTTTAAATTTGTTTCA-3
pET21b NdeI, BamHI pset8325-2
set6 8325 5-CAGTACATATGGCAGAATCAACTCAAGGTCAA-3,
5-CGGATCCTATTTATATTCTAGCTCAACAT-3
pET21b NdeI, BamHI pset8325-3
set7 8325 5-CTGTAACCATGGGTGAACATAAAGCAAAATAT-3,
5-AGGATCCTATCTAATGTTGGCTTCTATTTT-3
pET15 NcoI, BamHI pset8325-4
set8 COL 5-GCAGCACATATGACAACACCATCTTCCACTAAA-3,
5-CGGATCCTATTTCAAATTCACTTCGATGT-3
pET21b NdeI, BamHI pset2295
set9 COL 5-CGGTCCATATGGAAAAAATACAATCAACT-3,
5-TGGATCCTATTTTATATTCACTTCAATTG-3
pET21b NdeI, BamHI pset2298
set10 COL 5-CCAGTTCATATGGAAAAGAAACCTATTGTAATA-3,
5-TGGATCCTATGCTTTTATAACTTTGATTTG-3
pET21b NdeI, BamHI pset2300
set11 COL 5-CAGTACATATGAAAGCAGAAGTTAAACAACAA-3,
5-AGGATCCTATTTCATTTCTACTAGAATTT-3
pET21b NdeI, BamHI pset2301
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RESULTS
Characterization of structural variation in RD13. Analysis
of the RD13 region in seven sequenced S. aureus strains, COL
(http://www.tigr.org), 8325 (http://www.genome.ou.edu), meth-
icillin-resistant S. aureus (MRSA) 252 (Sanger MRSA) and
methicillin-susceptible S. aureus (MSSA) 476 (Sanger MSSA)
(http://www.sanger.ac.uk), N315 and MW2 (http://www.bio.n-
ite.go.jp), and Mu50 (GenBank accession no. NC_002758),
revealed that the gene order at this chromosomal site is well
conserved in all isolates. Allelic variants of six of the seven set
genes contained in RD13 in strain COL were present in all
seven sequenced strains (Fig. 1). A summary of the size and
degree of polymorphism among set genes in the seven se-
quenced strains is represented in Table 3. Analysis of the
degree of polymorphism among predicted SET proteins from a
single strain, COL, revealed 22.8 to 64.5% identity, and pair-
wise analysis of allelic variation among set genes common to
the seven sequenced strains revealed between 85 and 100%
identity at the nucleotide level. In addition, between 6 and 10
set variant genes were present in a central Vr depending on the
strain (Fig. 1).
In a previous study, Williams et al. (19) sequenced a 5.2-kb
DNA segment containing set genes from a human S. aureus
strain, NCTC6571 (Fig. 1). This fragment is identical to a
region internal to RD13 in the sequenced MRSA strain 252
and includes set2, set3, set5, set7, part of set8, and part of the
restriction-modification subunit gene. The prototype set1 gene
which was cloned and overexpressed in E. coli in the Williams
et al. study is an allele of set5 of the set gene family (Fig. 1).
PCR-RFLP analysis of RD13. To analyze structural varia-
tion in chromosomal region RD13 among S. aureus strains
representing the breadth of diversity within the species, a PCR-
RFLP method was developed. We analyzed 44 strains that
represent each of the major clonal complexes identified in an
MLEE population genetics study of more than 2,000 isolates
from diverse infection types, localities, and host species (12)
(Table 1). Twenty-seven distinct PCR-RFLP types were iden-
tified (Fig. 2; Table 1), indicating that substantial variation
exists at this chromosomal region in natural populations. Each
strain had 7 to 12 restriction fragments in total, which were
between 0.5 and 4.5 kb in length, and resulted in restriction
profiles that were readily distinguishable (Fig. 2). Most of the
27 PCR-RFLP types comprised relatively few isolates (range,
FIG. 2. (A) Schematic representation of 34 RD13 PCR-RFLP types identified among 44 S. aureus strains of divergent clonal lineage and 19
strains isolated from patients with invasive disease in Finland; (B) Vr PCR product size variants. Agarose gel electrophoresis of representative PCR
products amplified with primers specific for regions flanking the RD13 variable region.
TABLE 3. Mean proportion of homologous nucleotide and amino
acid sites within six SET genes and proteins common
to seven S. aureus strainsa
Gene
Inferred
amino acid
length in
strain COL
Proportion of
homologous
nucleotide sitesb
(mean  SE)
Proportion of
homologous
amino acid sitesc
(mean  SE)
set1 233 0.81  0.01 0.77  0.02
set2 239 0.95  0.01 0.94  0.01
set3 243 0.95  0.01 0.93  0.01
set9 359 0.92  0.01 0.87  0.01
set10 262 0.95  0.01 0.92  0.01
set11 246 0.89  0.01 0.83  0.02
a S. aureus strains analyzed were 8325, Sanger MSSA, Sanger MRSA, N315,
Mu50, COL, and MW2.
b Mean proportion of homologous nucleotide sites  1  mean p-distance (in
nucleotides). p-distance is the proportion (p) of nucleotide sites at which the
sequences compared are different. The standard error was calculated by the
bootstrap method.
c Mean proportion of homologous amino acid sites  1  mean p-distance (in
amino acids). The p-distance is the proportion (p) of amino acid sites at which
the sequences compared are different. The standard error was calculated by the
bootstrap method.
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one to six strains per type) (Table 1), which is indicative of
considerable genetic diversity in this region. Multiple PCR-
RFLP types were identified among isolates assigned to elec-
trophoretic type (ET) clusters A1, F2, F4, F5, F6, and H1.
There was little sharing of PCR-RFLP types between ETs. The
exceptions to this were strain MSA 565 (lineage F8/ET 178),
which shared PCR-RFLP type 3 with strains MSA 3426 (F2/
89), MSA 1006 (F3/91), and MSA 1007 (F3/1006); and strain
MSA 1134 (K1/249), which had an identical PCR-RFLP type
to strains MSA 820 and MSA 3400 (both F2/91). In addition,
MSA 2766 (F5/161) had an identical PCR-RFLP type 32 to
MSA 1183 of the I1 cluster. This PCR-RFLP typing method
had a very high index of discrimination of 0.962 (8). (An index
of 1.0 would indicate that a typing method was able to distin-
guish each member of a strain population from all other mem-
bers, whereas an index of 0.0 would indicate that all members
of the population were of an identical type.) Taken together,
these data clearly indicate a high degree of genetic diversity at
this chromosomal region.
We also analyzed the RD13 PCR-RFLP patterns of 19
S. aureus isolates recovered from patients with invasive infec-
tions whose sera were used in Western immunoblot analysis
(see below). Among these 19 organisms, 7 had RD13 PCR-
RFLP profiles which were identical to type 13 or differed by
the presence of one or two restriction sites (types 33 and 34).
Two isolates were PCR-RFLP type 16; there were single iso-
lates of type 2, type 6, type 8, and type 15; and five isolates had
unique RD13 PCR-RFLP profiles (types 27 to 31). A PCR
product could not be generated for one isolate.
PCR analysis of the Vr of RD13. PCR amplification was used
to determine the size of the Vr among the 63 strains used in
this study (Fig. 2). The primers used were specific for nucleo-
tides located approximately 700 and 800 bp upstream and
downstream, respectively, of the Vr. The estimated size of the
Vr was calculated by subtracting 1.5 kb from the size of the
PCR product. Three strains had Vrs of 7 kb, 5 strains had Vrs
of 8 kb, 19 strains had Vrs of 9 kb, 17 strains had Vrs of 10 kb,
and 19 strains had Vrs of 11 kb (Table 1). Based on the set gene
content of the Vrs in the six sequenced strains, these results are
consistent with the presence of 6, 7, 8, 9, or 10 set genes in this
chromosomal region in S. aureus strains.
Phylogenetic analysis of RD13. Phylogenetic analysis was
used to reconstruct the evolutionary history of the RD13 locus
and to determine the extent that recombination contributed to
the divergence of the region (Fig. 3). To add to the publicly
available genome sequences of S. aureus strains 8325, Sanger
MSSA, Sanger MRSA, N315, Mu50, and COL, DNA sequenc-
ing of variably present set genes (Vr) of 12 selected strains was
carried out. Strains were selected based on Vr size variation
and clonal diversity (determined by MLEE) (strains 1006,
1260, 141, 143, 145, 147, 232, 240, 3400, 3402, 537, and 554).
The set4, set5, set6, set7, and set8 genes were found to be
variably absent in the strains examined. A phylogenetic tree
was constructed from the concatenated nucleotide sequences
of orf2, set1, res, mod, set2, set3, set9, set10, and set11 (i.e., genes
in RD13 that are common to all strains) from the previously
sequenced strains 8325, Sanger MSSA, Sanger MRSA, N315,
Mu50, and COL to represent the conserved architecture of the
RD13 locus. The topology of this tree was compared to the
topologies of the individual gene trees of set4 (strains MSA
1006, MSA 1260, MuSA 145, MSA 3400, MSA 3402, 8325,
Sanger MSSA, Mu50, and N315), set5 (strains MSA 1006,
MSA 1260, MuSA 141, MuSA 143, MuSA 145, MSA 3400,
MSA 3402, MSA 537, 8325, Sanger MRSA, Sanger MSSA,
Mu50, N315, and NCTC6571), set6 (strains MSA 1006, MSA
3402, 8325, and Sanger MSSA), and set7 (strains MSA 1006,
MSA 1260, MuSA 141, MuSA 143, MuSA 145, MuSA 147,
MuSA 232, MuSA 240, MSA 3400, MSA 3402, MSA 537, MSA
554, 8325, Sanger MRSA, Sanger MSSA, Mu50, N315, and
NCTC6571). Extensive recombination would result in set genes
composed of segments of DNA with different evolutionary
histories and conflicting phylogenetic topologies. However, we
found that the topology representing the conserved regions of
RD13 and each of the individual topologies constructed for
genes set4 to set7 were consistent, suggesting that recombina-
tion had not occurred at a sufficiently high frequency to distort
the phylogenetic signal.
The analysis suggested two models for the evolution of the
RD13 locus (Fig. 3). One model requires a common ancestor
which has only set5 and set7. The present-day complement of
set genes in each lineage would have arisen through multiple
acquisition and deletion events. In this case, one would expect
less variation in the form of synonymous (silent) nucleotide
substitutions in the recently acquired set genes. However, our
analysis indicated that the proportions of polymorphic synon-
ymous sites in set4 to set7 are very similar, a result inconsistent
with this model. Alternatively, the ancestral state could be
represented by a complete complement of set genes in the Vr.
In this model, extant states are explained by the loss of set
genes in parallel in separate lineages of pathogenic S. aureus
(Fig. 3). The occurrence of similar proportions of synonymous
sites strongly supports this idea. Taken together, these analyses
suggest that the evolution of the RD13 locus is explained by a
model in which the loss of set genes has occurred several times
independently in separate lineages of pathogenic S. aureus
(Fig. 3). While the extent of horizontal gene transfer has been
insufficient to mask the phylogenetic signal present, recombi-
nation may have contributed to chromosomal diversification at
the RD13 locus. To investigate this possibility, the maximum
	2 method was used to identify putative end points of past
recombination. Multiple end points flanking small regions of
the sequence throughout the RD13 locus were identified (data
not shown). The largest of these regions was identified in the
res gene based on a comparison of six strains (Fig. 3). Re-
stricted allelic variation within the recombined segments of the
res gene suggests that recombination has occurred recently.
Analysis of the level of selective constraint acting on set
genes. Considering the high level of predicted homology
among SET proteins produced by a single strain, it is conceiv-
able that SETs may have some redundancy of function. Ac-
cordingly, we examined the possibility that one or more set
genes may have become silent. Silent genes are free to accu-
mulate synonymous (silent) mutations and corresponding
amino acid replacements, as selective constraint is no longer
acting to maintain protein function by limiting deleterious
amino acid replacements. To determine if the level of selective
constraint varies across RD13, we calculated pN and pS for
subsets of 30 codons in a sliding window for the length of each
set gene (Fig. 4). The difference, pN  pS, is a measure of the
degree of selective constraint. The more negative the value, the
2832 FITZGERALD ET AL. INFECT. IMMUN.
FIG. 3. Two models for the evolution of the RD13 chromosomal region and the Vr. The trees were constructed by the neighbor-joining algorithm
based on the number of synonymous substitutions per synonymous site (dS). A comparison of phylogenetic trees constructed from individual set
gene nucleotide data and a concatenated sequence representing the conserved genes of RD13 indicated that the topologies were cognate. Thus, the
extent of recombination present was insufficient to disrupt the underlying phylogenetic signal. The set9 gene tree is shown. Bootstrap confidence
limits are shown under the major nodes. The proposed ancestral state of the Vr is indicated at the hypothetical root. The gain and loss of set genes
necessary to explain the extant state of each strain are indicated in red. (A) Evolution of RD13 and the Vr explained solely by the loss of set genes
over time. This (preferred) model is supported by the observation that the proportion of silent mutations (synonymous substitution) within each set
gene is the same. (B) Evolution of RD13 explained by both the gain and loss of set genes over time (alternative model). This model is not supported
by an analysis of the proportion of polymorphic synonymous sites present in each set gene. While other models are possible, they require a larger
number of evolutionary events (i.e., gain or loss), making them less likely. (C) Recombination has occurred within RD13. A Happlot analysis of
the orf2, set1, and res genes in six representative strains is shown. Polymorphic nucleotide sites based upon pairwise comparisons are represented
by vertical lines. Putative areas of recombination, regions of similar nucleotide sequence in different genetic backgrounds, are represented in red.
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less the contribution of amino acid replacements and the
greater the contribution of synonymous nucleotide substitu-
tions. A difference of zero indicates selectively neutral varia-
tion, where the per-site rates of synonymous and nonsynony-
mous substitutions are equal. A positive difference (i.e., amino
acid replacements exceeding silent substitutions) suggests the
action of diversifying (positive) selection. Overall, the pN  pS
difference is consistently negative for each of the set genes, a
value indicative of purifying selection (Fig. 4). The set9 gene
did possess a single region 53 codons in length, stretching from
position 17 to position 69, in which the value for pN  pS was
0. In this region, the rate of substitution per 100 sites is
expressed by the equations dN  9.3 2.1 and dS  10.1 3.8.
The results suggest that if any of the set genes were silenced, it
was a very recent event given that the number of corresponding
amino acid replacements has not had sufficient time to accu-
mulate substantially.
Expression of genes located in RD13 in S. aureus strain
COL. To test the hypothesis that the genes in RD13 are tran-
scribed, TaqMan assays were used to determine relative gene-
specific mRNA levels present in mid-exponential and station-
ary-phase S. aureus cells (Fig. 5) by using the oligonucleotides
listed in Table 4. No transcript was detected in either expo-
nential- or stationary-phase cells for set1, hypothetical orf5, and
the putative transposase (tra) genes, a result indicating that
these three genes are not transcribed in vitro at these time
points under the conditions studied. In contrast, all other genes
examined were either constitutively expressed during the
growth cycle (res, mod, and set2) or were up-regulated in the
stationary phase of growth (orf1 to orf3, orf5, set3, set8, set9,
set10, and set11) (the cutoff was a 1.5-fold increase in the
normalized transcript level).
Western blot analysis of recombinant SET proteins with
sera from patients with invasive S. aureus infections. To de-
termine if SET proteins are expressed during the course of
human infection and stimulate a humoral immune response,
Western immunoblot analysis of recombinant SET proteins
was carried out with paired acute- and convalescent-phase
serum samples from 19 patients with S. aureus bacteremia. Of
the panel of 11 recombinant SET proteins, 6 were immunore-
active with sera obtained from at least one patient, indicating
expression of these proteins during human infection (Table 5).
SET2, SET4, SET5, SET8, SET9, and SET10 were reactive
with sera from 13, 1, 4, 12, 18, and 3 of the 19 patients exam-
ined, respectively. SET1, SET3, SET6, SET7, and SET11 were
not reactive with any of the 19 patient sera. Of the 11 recom-
binant proteins, only SET9 was reactive with any of the eight
control sera tested (n  2) (data not shown). A representative
Western blot is shown in Fig. 6.
FIG. 4. Graphic display of the degree of selective constraint across a representative portion of RD13. The pN and pS nucleotide substitutions
are indicated by the red and blue lines, accordingly. The black line represents the difference (pN  pS), which is a measure of the degree of selective
constraint. The more negative the value, the less the contribution of amino acid replacements and the greater the contribution of synonymous-
nucleotide substitutions. Overall, the difference (pN  pS) is consistently negative for each of the set genes, indicative of purifying selection.
Polymorphic nucleotide sites based upon pairwise comparisons are represented by vertical lines.
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Biological activity of SET6. We next assessed whether a
representative protein (SET10) encoded by a gene in the
RD13 locus (Fig. 1) had superantigenic activity. In a standard
assay, SET6 was unable to stimulate rabbit splenocyte or hu-
man PBMC proliferation whereas TSST-1 (positive control
protein) stimulated proliferation of both rabbit splenocytes
and human PBMCs (data not shown).
The pyrogenic activity of purified SET6 and its ability to
enhance endotoxic shock also were examined. SET10 did not
cause fever in rabbits at a dose of 10 g/kg and did not enhance
the lethality of endotoxin administered to rabbits. TSST-1 ad-
ministered at the same dose was pyrogenic and enhanced the
lethality of endotoxin (data not shown).
DISCUSSION
Several comparative genomic studies have highlighted the
extensive variation that exists within natural populations of
some pathogenic bacteria, but the molecular mechanisms of
genome diversification are still unclear. We identified exten-
sive variation in RD13, a region of the chromosome that is
common to all strains of S. aureus examined. This variation
included the sequence divergence of genes common to all
strains and differences in gene content, as indicated by RD13
FIG. 5. (A) Growth curve of S. aureus strain COL. Total RNA was
isolated from S. aureus cells grown in tryptic soy broth at 37°C to the
A600 values and time points indicated by the dashed lines. (B) Relative
quantities of RD13 reverse-transcribed mRNA normalized to the in-
ternal control era, determined by Taqman assays.
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PCR-RFLP, size, and DNA sequence analyses. The seven S.
aureus strains whose genomes have been sequenced had an
RD13 central Vr of 7, 9, 10, or 11 kb corresponding to 6, 8, 9,
or 10 set genes, respectively (Fig. 1). Most of the 63 strains
examined by PCR had an RD13 with one of these Vr size
variants. However, four strains had a Vr of 8 kb, consistent
with the presence of seven set genes in the Vrs in these strains.
This inference was confirmed by DNA sequencing.
The presence of a large and variable number of set genes and
the observed sequence divergence in the RD13 locus suggested
that molecular evolutionary genetic analysis would provide in-
sight into the processes shaping variation in this region. To
investigate the evolution of RD13, we adopted a strategy in
which separate phylogenies were constructed to represent the
conserved architecture of the locus and the variable set genes.
The analysis suggested two models of evolution for RD13 (Fig.
3). One model requires a common ancestor which possesses
only set5 and set7. In this situation, multiple gene acquisition
and gene loss events would have led to the present-day com-
plement of set genes in each lineage. However, based on a
similar proportion of synonymous (silent) nucleotide substitu-
tions in all set genes in the Vr, the most likely scenario is that
an ancestral strain with a full complement of set genes in the Vr
underwent multiple independent losses of set genes in parallel
in distinct lineages. In each case, the set gene losses were
confined to the set4 to set8 genes. It is unlikely that there is a
selective disadvantage to possessing one or more of the set4 to
set8 genes, as two strains (8325 and MSSA) have a copy of each
gene in their extant states. In addition, analysis of nucleotide
substitution in the set4 to set8 genes did not reveal a marked
decrease in functional constraint that may accompany a dele-
terious allele.
The presence of RD13 in all strains representing the major
clonal lineages within the species and the existence of a GC
content which is equivalent to that of the S. aureus genome
both suggest that RD13 is an ancient feature of the S. aureus
chromosome. DNA sequence analysis indicated that horizontal
gene transfer and recombination have contributed to the di-
versification of RD13 in different strains (Fig. 3). The presence
of a transposase gene in this region supports this theory, al-
though this gene was not expressed in strain COL under the
conditions studied and has been lost altogether by the recently
FIG. 6. (A) Immunogenicity of recombinant SET proteins with hu-
man patient sera. SDS-PAGE gel of lysates of E. coli expressing re-
combinant SET protein variants. Lanes 1 to 11, SET1 to SET11, re-
spectively; lane 12, lysate of E. coli containing the expression vector only.
Note that SET8 and SET9 resolve at approximately twice their expect-
ed molecular weight, thus indicating a dimeric form of the protein (see
Western blot analysis in panel B). (B) Representative Western blot
analysis of recombinant SET proteins with convalescent-phase serum
from human patient 2. Lanes 1 to 11, SET1 to SET11, respectively.
TABLE 5. Immunoreactivity of recombinant SET proteins with
human patient sera by Western blot analysis
Patient
serum
samplea
Reactivity of recombinant SET proteinb
SET1 SET2 SET3 SET4 SET5 SET6 SET7 SET8 SET9 SET10 SET11
1a     
1c     
2a   
2c   
3a 
3c   
4a 
4c   
5a 
5c 
6a  
6c  
7a
7c 
8a     
8c      
9a  
9c    
10a 
10c  
91a 
91c  
92a   
92c   
93a  
93c   
94a
94c 
96a 
96c 
97a   
97c 
98a  
98c   
99a   
99c   
100a  
100c  
a Human serum samples were obtained from individuals with invasive episodes
of S. aureus infection in Finland in 1999 and 2000. Patients had infections with or
without deep infection foci, including abscesses, spondylitis, amnionitis, foreign
body infections, pneumonia, and purulent arthritis. Sera were obtained 2 to 7
days after the first positive blood culture (a, acute phase) and 20 to 30 days
postinfection (c, convalescent phase).
b , positive reactivity.
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sequenced strain MW2. The presence of many related but not
identical set genes is suggestive of distant gene amplification
events followed by sequence divergence which resulted in a
common S. aureus ancestor with a full complement of set genes
in RD13 (Fig. 3).
Our data show that the restriction-modification system
genes in RD13 are expressed in vitro. Interestingly, restriction-
modification system genes are found in another large variable
region in the S. aureus chromosome adjacent to a cluster of six
genes encoding a family of serine proteases (6). The signifi-
cance of their close proximity has yet to be established, but it
is possible that restriction-modification systems may have
played a role in the evolution or regulation of some paralogous
gene families in the S. aureus chromosome.
DNA sequence analysis of the ratio of synonymous nucleo-
tide substitutions in set genes to amino acid substitutions in
their products suggested that the functionality of set genes has
been maintained by purifying selection (Fig. 4). Gene expres-
sion assays indicated that only one of seven set genes (set1) in
strain COL was not expressed in vitro under the conditions
tested. The set genes were expressed in a growth-phase-depen-
dent manner (Fig. 5) with the highest transcription levels de-
tected during the stationary phase of growth. In this regard, the
set genes are similar to many staphylococcal exotoxin genes
associated with virulence which are typically up-regulated pos-
texponentially. Of note, the set genes were expressed concur-
rently, suggesting that multiple SET proteins may participate
in host-pathogen interactions simultaneously. The identifica-
tion of putative promoters upstream of several set genes (data
not shown) suggests that the set genes may be encoded by
multiple transcripts. The cotranscription of six set genes also
indicates that a mechanism of phase variation mediated by
gene cassette switching does not occur at this locus. Consider-
ing the evident selective constraint on SET proteins, it is likely
that set gene deletions are a relatively rare occurrence. Of note,
no RD13 gene deletions were observed during continuous in
vitro passage of a clinical strain of S. aureus for a 6-week
period, thus indicating the stability of this chromosomal region
during growth in vitro (17).
The evolutionary basis for maintenance of production of
many related SET proteins by S. aureus is unclear. However,
the data indicate that multiple SET proteins are expressed
during human infection and induce a humoral immune re-
sponse. Although all patient sera examined contained antibod-
ies to one or more recombinant SET proteins from strain COL
or 8325, not all SET variants were immunoreactive. The pos-
sibility that different strains may produce antigenically distinct
SET variants is consistent with the variation in the set gene
content and DNA sequence identified in different strains. It is
conceivable that SET allelic variation may represent a mech-
anism of immune avoidance employed by S. aureus which may
encounter hosts that have already been exposed to SET pro-
teins during previous staphylococcal infections. Alternatively,
the variation in immunoreactivity in human patient sera may
be explained by the possibility that some SET proteins did not
elicit a strong immune response or are poorly expressed in
some strains. The SET protein family may have evolved as a
result of the occurrence of host receptors which are polymor-
phic between individuals, such that the production of many
SET proteins may increase the chances of effective interaction
with such receptors. However, it is also conceivable that al-
though the SET proteins have high sequence homology and
similar predicted structures, each protein has a related but
distinct function in host-pathogen interactions.
We examined a SET variant (SET6) for superantigen activ-
ity. In spite of the presence of the two superantigen consensus
domains, SET6 did not have the classical properties of super-
antigens such as superantigenicity, pyrogenicity, or enhance-
ment of endotoxic shock (data not shown). This finding is
consistent with that of a recent study (1) of a different SET
variant (SET3), which indicates that SET proteins may have
biological activities that are distinct from those of superanti-
gens. The study by Arcus et al. (1) suggests that SET proteins
have some of the characteristics of DNA-binding proteins, and
further analysis will help define a clearer role for SET proteins
in pathogenesis.
In this study, we explored the molecular evolution of a large
chromosomal region common to all strains of S. aureus which
encodes a family of proteins putatively involved in pathogen-
esis. We found extensive genetic diversity and variation in the
set gene content at the chromosomal region RD13 within the S.
aureus species, and we proposed a likely evolutionary scenario
for the locus in contemporary pathogenic S. aureus strains that
involves multiple episodes of set gene deletion in different
clonal lineages in parallel. We also found that horizontal gene
transfer and recombination have contributed to the diversifi-
cation of this chromosomal locus. Functional constraint is act-
ing to maintain the expression of set genes, and multiple SET
proteins are expressed during human infections, suggesting a
possible role in host-pathogen interactions. Taken together,
these findings represent new insights bearing on the evolution
and diversification of the genome of pathogenic S. aureus.
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